Anbio Biotechnology (NASDAQ:NNNN – Get Free Report) shares gapped down prior to trading on Tuesday . The stock had previously closed at $32.52, but opened at $31.00. Anbio Biotechnology shares last traded at $32.42, with a volume of 4,629 shares changing hands.
Wall Street Analyst Weigh In
Separately, Weiss Ratings raised shares of Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, May 14th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, Anbio Biotechnology currently has an average rating of “Hold”.
Check Out Our Latest Report on NNNN
Anbio Biotechnology Stock Performance
Anbio Biotechnology (NASDAQ:NNNN – Get Free Report) last released its quarterly earnings data on Tuesday, April 7th. The company reported $0.03 EPS for the quarter.
Anbio Biotechnology Company Profile
Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.
Further Reading
- Five stocks we like better than Anbio Biotechnology
- Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
- 2 Aluminum Stocks Poised for Big Tariff-Related Gains
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
Receive News & Ratings for Anbio Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anbio Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
